简体中文 | 繁體中文 | English

Press Releases

2020-04-29 09:26 Moody's Analytics Launches SolvencyWatch™ Solution for Insurers’ Capital Monitoring
2020-04-29 09:19 “Restart Your Business with BV”
2020-04-29 09:00 Moody’s Analytics RiskCalc™ and CMM™ Solutions Complete SOC 1® Examinations
2020-04-28 13:31 ABB: Q1 2020 Results
2020-04-28 11:50 Taulia Announces Strategic Alliance with J.P. Morgan
2020-04-28 10:23 Alibaba Named by Gartner as Third Biggest Global Provider for IaaS and First in Asia Pacific
2020-04-28 09:50 Making the Decision to Apply to UNNC in 2020?
2020-04-28 09:47 Elliptic Labs Launches Two New Design Wins with Xiaomi Mi 10 Youth and Mi 10 Lite Smartphones
2020-04-27 19:03 CEPI Announces COVID-19 Vaccine Development Partnership With Clover Biopharmaceuticals’ Australian Subsidiary
2020-04-27 18:09 IDEMIA Provides Seamless Biometric Access Control to Digital Garage’s New Headquarters in Japan
2020-04-27 18:07 EMQ Delivers Enhanced Cross-border Payment Capabilities to SMEs and Payment Service Providers in Singapore
2020-04-27 16:48 CoinEx Announces Global Strategic Partnership with Matrixport to Provide Over-the-counter Service
2020-04-27 16:43 Society for Human Resource Management (SHRM) To Offer Prometric’s ProProctor™ Online Proctoring Solution
2020-04-27 15:50 MHPS Announces New Company Name “Mitsubishi Power”
2020-04-27 15:30 Conic Provides Update on Timing of Reporting of 2019 Financial Results Due to Delays Caused by COVID-19
2020-04-27 10:17 Rosewood Hotel Group Launches Rosewood Raise, a Relief Initiative to Support Associates and Communities Affected by COVID-19
2020-04-24 20:38 Immersion and Alps Alpine Announce a New Level of Partnership With Active Sensing™ Technology License
2020-04-24 17:34 Happiness Continues for Jonas Brothers Fans With an All New Concert Documentary Premiering Tomorrow, Friday April 24, 2020 Exclusively on Amazon Prime Video
2020-04-24 16:37 Opentrons Partners With Zymo Research To Offer an Affordable, Automated COVID-19 Testing Platform
2020-04-24 15:17 Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core Assets in Europe to Orifarm for Up to Approximately $670M USD